How do I calculate fluid restriction for a pediatric patient with poststreptococcal glomerulonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fluid Restriction Calculation for Pediatric PSGN

For pediatric patients with post-streptococcal glomerulonephritis (PSGN), restrict maintenance fluid therapy to 50-60% of the volume calculated by the Holliday-Segar formula to prevent fluid overload and its life-threatening complications.

Calculation Method

Start with the Holliday-Segar formula to determine baseline maintenance fluid requirements:

  • 0-10 kg: 100 mL/kg/day
  • 11-20 kg: 1000 mL + 50 mL/kg for each kg above 10 kg
  • >20 kg: 1500 mL + 20 mL/kg for each kg above 20 kg

Then multiply this calculated volume by 0.5 to 0.6 (50-60%) to determine the restricted fluid allowance 1.

Rationale for Restriction

PSGN creates an edematous state with renal failure, placing these children at extremely high risk for:

  • Pulmonary edema (occurs in up to 23.4% of cases) 2
  • Hypertensive emergencies and encephalopathy
  • Congestive heart failure 3, 4

The 2022 ESPNIC guidelines specifically identify children with renal failure as requiring the most aggressive fluid restriction (50-60% of Holliday-Segar), which is more restrictive than the 65-80% recommended for children with isolated increased ADH secretion 1.

What to Include in Total Fluid Calculation

Count ALL fluid sources toward the restricted total 1:

  • IV maintenance fluids
  • All IV medications (both infusions and bolus drugs)
  • Blood products
  • Arterial and venous line flush solutions
  • Enteral intake (oral or tube feeding)

Do NOT include: replacement fluids for ongoing losses or massive transfusion protocols.

Fluid Composition

Use isotonic balanced solutions (e.g., Plasma-Lyte, Ringer's lactate) rather than normal saline 1. Add appropriate potassium based on serum levels and clinical status, monitoring at least daily 1.

Critical Monitoring Requirements

Reassess at least daily 1:

  • Fluid balance (strict intake/output)
  • Clinical status (edema, blood pressure, respiratory status)
  • Electrolytes, especially sodium
  • Renal function

Treatment of Fluid Overload

When hypervolemia develops despite restriction, urgently treat with loop diuretics 4. In severe cases with pulmonary edema or respiratory distress, renal replacement therapy (dialysis) may be required 3, 4, 5. Delayed recognition of pulmonary edema in PSGN has led to respiratory failure and unnecessary interventions when misdiagnosed as pneumonia 5.

Common Pitfall

Do not use standard (100%) maintenance fluids in PSGN. The salt and water retention in PSGN is severe and can be life-threatening 4. The combination of acute kidney injury and glomerular inflammation creates profound volume overload risk that demands aggressive restriction from the outset, not after complications develop.

Additional Supportive Measures

Beyond fluid restriction, management includes 6, 3:

  • Sodium restriction <2.0 g/day (<90 mmol/day) to reduce edema and control blood pressure
  • Antihypertensive therapy as needed
  • Diuretics (loop diuretics preferred)
  • Monitoring for resolution (most resolve within 3 months, though 6.5% may have persistent abnormalities) 2

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.